The current prices are delayed, login to your account for live prices
LOGIN
Create Alert
Watchlist

Dr Reddy's Laboratories

1177.90
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Overview
News
Events
F&O

Performance

Open
1,210.30
Prev. Close
1,177.90
Volume
28,60,907
Total traded value
337 Cr
Upper Circuit
1,295.65
Lower Circuit
1,060.15

Analyst Estimates

51%
Buy
51%
Hold
22%
Sell
27%
Aggregated by Refinitiv from 37 Analysts

Fundamentals

Market Cap₹1,00,969Cr
ROE17.36%
P/E Ratio(TTM)18.80
EPS(TTM)64.37
P/B Ratio3.28
Dividend Yield0.66%
Industry P/E34.57
Book Value368.50
Debt to Equity0.16
Face Value1
Understand Fundamentals

Financials

Revenue
Profit
Net Worth
*All values are in Rs. Cr
7,4537,3117,8838,3468,531Dec '23Mar '24Jun '24Sep '24Dec '24
Quarterly
Yearly

About Dr.reddy's Laboratories Ltd

Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The Company’s segments include Pharmaceutical Services and Active Ingredients, Global Generics, and Others. The Pharmaceutical Services and Active Ingredients segment primarily consists of the Company’s business of manufacturing and marketing APIs and intermediates. The Global Generics segment consists of the Company’s business of manufacturing and marketing prescription and OTC finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics).;
Parent OrganisationDr.reddy's Laboratories Ltd
Managing DirectorMr. Gunupati Prasad
NSE SymbolDRREDDY

Shareholding Pattern

Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Foreign Institutions
40.08%
Promoters
26.64%
Other Domestic Institutions
11.76%
Mutual Funds
11.14%
Retail And Others
10.38%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
NA
(0.00%)
37.47
Cipla
NA
(0.00%)
24.67
Mankind Pharma
NA
(0.00%)
47.95
Lupin
NA
(0.00%)
33.76
Groww
Want to invest in this stock?
Open a free Demat account in minutes to start investing in stocks.
ⓒ 2016-2025 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.9.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW